| Q45016019 | Attenuation of small-for-size liver graft injury by FTY720: significance of cell-survival Akt signaling pathway. |
| Q41951630 | Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study |
| Q47300684 | FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway. |
| Q79959742 | FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model |
| Q45214556 | FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. |
| Q44299688 | FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia; impact on long-term survival and T-lymphocyte tissue infiltration |
| Q46936581 | Fat-derived hormone adiponectin combined with FTY720 significantly improves small-for-size fatty liver graft survival. |
| Q47339438 | Implanted adipose-derived stem cells attenuate small-for-size liver graft injury by secretion of VEGF in rats |
| Q28303535 | Mesenchymal stem cells over-expressing hepatocyte growth factor improve small-for-size liver grafts regeneration |
| Q36589486 | Microarrays: a monitoring tool for transplant patients? |
| Q43235979 | Protective effects of early CD4(+) T cell reduction in hepatic ischemia/reperfusion injury |
| Q45789352 | Protective effects of simultaneous splenectomy on small-for-size liver graft injury in rat liver transplantation |
| Q56750684 | Rapamycin attenuates liver graft injury in cirrhotic recipient--the significance of down-regulation of Rho-ROCK-VEGF pathway |
| Q37317375 | Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response |
| Q36889221 | Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury |
| Q34977062 | Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation |
| Q36280426 | Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications |
| Q38217423 | Small-for-size syndrome in living-donor liver transplantation using a left lobe graft |
| Q42168904 | Splenic artery ligation improves remnant liver function in partially hepatectomized rats with ischemia/reperfusion injury |
| Q37325921 | Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts |